This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm: Carotid body
CD2_BENIGN_CAROTIDBODY_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Carotid body
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Carotid body
- Benign neoplasm of other and unspecified endocrine glands
- Benign neoplasm of other and unspecified endocrine glands
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 98 | 59 | 39 |
| Unadjusted period prevalence (%) | 0.02 | 0.02 | 0.02 |
| Median age at first event (years) | 53.73 | 52.16 | 56.13 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 86
- Matched controls
- 859
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D35.59
ICD-10 Finland
Other paragangliom
+∞
72.4
59
*
D35.50
ICD-10 Finland
Carotid body
+∞
40.9
36
*
WX408
NOMESCO Finland
General anesthesy, balanced
8.4
17.4
47
107
BDA10
NOMESCO Finland
Operation on carotid body
+∞
16.1
15
*
H02AB09
ATC
hydrocortisone; systemic
25.5
11.1
15
7
WF002
NOMESCO Finland
Radical radiotherapy
+∞
10.6
10
*
Z31.5
ICD-10 Finland
Genetic counselling
16.0
10.2
16
12
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
+∞
9.5
9
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
9.8
9.5
19
24
XX3DW
NOMESCO Finland
Time consuming IT work
14.8
9.3
15
12
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
27.5
9.2
12
5
102
Kela drug reimbursment
Diabetes insipidus
99.4
8.6
9
*
E23.00
ICD-10 Finland
Panhypopituitarism
99.4
8.6
9
*
101
Kela drug reimbursment
Anterior pituitary hypofunction
99.4
8.6
9
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
37.2
8.3
10
*
JN4BD
NOMESCO Finland
Extensive body CT
11.7
7.9
14
14
116
Kela drug reimbursment
Prostate cancer
+∞
7.4
7
*
JN5ER
NOMESCO Finland
PET-CT of receptors in whole body
+∞
7.4
7
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
7.4
7
*
D35.30
ICD-10 Finland
Craniopharyngoma
+∞
7.4
7
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
7.4
7
*
D35.9
ICD-10 Finland
Benign neoplasm: Endocrine gland, unspecified
+∞
7.4
7
*
E27.5
ICD-10 Finland
Adrenomedullary hyperfunction
+∞
7.4
7
*
8680/3-C75.5
ICD-O-3
Paraganglioma, NOS, of aortic body and other paraganglia
+∞
7.4
7
*
9350/1-C75.2
ICD-O-3
Craniopharyngioma, NOS, of craniopharyngeal duct
+∞
7.4
7
*
L02AE02
ATC
leuprorelin; implant, parenteral
43.6
6.9
8
*
TPH07
NOMESCO Finland
Cathetrisation of artery
6.4
6.6
17
32
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
15.9
6.6
10
7
D14.0
ICD-10 Finland
Benign neoplasm: Middle ear, nasal cavity and accessory sinuses
75.2
6.5
7
*
DCB00
NOMESCO Finland
Excision of lesion of middle ear
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
38
12
51.09
61.16
4.6
1.3
0.2
—
nmol/l
—
13
0
37
6
97.31
35.03
4.6
1.0
2.9
6.1
nmol/l
—
37
6
66
331
4.04
9.98
6.4
7.3
1.2
1.2
mmol/l
0.60
51
284
62
310
3.72
9.16
4.7
4.2
—
—
—
0
0
20
65
3.61
5.43
4.5
17.3
2.0
1.4
mmol/l
0.27
15
54
9
8
12.22
5.41
1.0
1.3
—
—
—
0
0
20
67
3.49
5.18
4.4
3.0
—
—
—
0
0
32
147
2.75
4.84
1.8
2.3
—
—
—
0
0
22
92
2.79
3.90
2.5
1.6
—
—
—
0
0
89
740
3.20
3.44
4.6
4.7
1.7
1.8
mu/l
0.16
82
678
9
19
5.10
3.33
1.9
3.9
—
—
—
0
0
6
8
7.89
3.10
1.3
1.0
—
—
—
0
0
12
40
3.28
3.09
4.8
10.7
24.8
25.5
mmol/l
0.21
12
40
32
181
2.14
2.91
3.8
3.8
0.0
0.0
estimate
0.00
13
59
32
183
2.11
2.82
2.9
3.0
1336.9
1096.7
ng/l
0.11
27
145
47
311
1.98
2.77
2.8
2.6
73.8
77.1
nmol/l
0.30
41
277
39
245
1.98
2.64
2.4
2.4
50.4
54.3
u/l
0.42
39
225
87
736
2.62
2.45
17.0
9.6
83.9
83.8
ml/min/173m2
0.01
77
576
27
154
2.04
2.36
3.3
3.4
106.7
108.7
ng/l
0.01
17
110
5
9
5.78
2.24
1.4
1.1
—
—
—
0
0
7
20
3.68
2.10
1.9
1.9
—
—
—
0
0
7
21
3.51
2.00
2.0
2.0
—
—
—
0
0
10
41
2.60
1.82
5.8
13.0
0.4
0.8
%
—
10
41
41
291
1.70
1.75
4.1
3.3
—
—
—
0
0
13
66
2.12
1.51
2.3
1.5
—
—
—
0
0
13
67
2.08
1.46
2.5
1.5
—
—
—
0
0
55
436
1.60
1.45
8.4
7.0
4.5
4.3
e9/l
0.20
49
366
49
381
1.57
1.38
3.9
3.3
0.0
0.0
estimate
0.00
13
57
9
43
2.20
1.34
1.6
1.6
—
—
—
0
0
24
158
1.69
1.31
3.3
3.4
17.8
24.8
%
1.53
14
69
5
18
2.87
1.30
1.0
1.2
—
—
—
0
0
5
18
2.87
1.30
1.0
1.2
—
—
—
0
0
48
376
1.54
1.28
5.3
4.6
0.0
0.0
estimate
0.00
13
62
47
374
1.49
1.13
3.9
3.3
0.0
0.0
estimate
0.00
13
63
8
41
2.03
1.11
6.5
13.1
1.1
1.6
%
—
8
41
7
132
0.49
1.09
1.4
1.4
—
—
—
0
0
88
811
1.83
1.00
17.2
11.1
23.2
21.4
mg/l
0.21
75
593
35
268
1.48
0.99
3.8
3.1
17.2
34.0
ng/l
1.05
27
163
0
26
0.00
0.79
0.0
1.3
—
—
—
0
0
5
26
1.97
0.71
1.4
1.3
—
—
—
0
0
5
27
1.90
0.69
3.0
3.7
23.5
25.1
mmol/l
—
5
27
5
27
1.90
0.69
1.2
1.7
23.8
53.5
u/ml
—
5
27
7
44
1.64
0.66
4.6
2.9
5.1
5.2
kpa
—
7
38
31
249
1.36
0.65
3.4
2.8
—
—
—
0
0
5
30
1.70
0.62
1.0
2.1
—
—
—
0
0
16
116
1.45
0.59
2.0
2.5
0.8
0.8
ug/l
—
10
74
77
818
0.73
0.56
4.8
4.7
2.6
2.8
mmol/l
1.40
69
755
75
798
0.74
0.53
4.4
4.3
1.5
1.5
mmol/l
0.29
69
736
9
65
1.42
0.52
2.3
2.0
5.1
6.1
ug/l
—
9
59
16
122
1.37
0.46
1.6
1.6
700.9
1214.9
nmol/l
—
8
91
6
94
0.61
0.44
1.5
1.7
—
—
—
0
0
0
15
0.00
0.41
0.0
1.9
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.3
—
5.5
—
0
8
5
35
1.45
0.40
1.4
1.3
—
—
—
0
0
18
146
1.29
0.35
1.3
1.3
11.9
21.4
iu/ml
—
10
52
77
803
0.81
0.31
4.5
4.3
4.6
4.7
mmol/l
0.61
70
745
73
765
0.82
0.31
3.9
3.9
1.6
1.3
mmol/l
1.11
68
698
78
751
1.19
0.23
6.3
5.3
39.1
39.5
mmol/mol
0.14
72
714
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
8.7
—
0
5
9
113
0.78
0.21
1.7
2.5
—
—
—
0
0
20
226
0.86
0.20
2.0
1.7
1.4
1.4
mmol/l
0.05
14
197
79
767
1.15
0.17
5.1
4.2
5.9
5.9
mmol/l
0.01
72
703
7
87
0.79
0.15
11.9
5.6
—
—
—
0
0
9
105
0.84
0.14
1.7
2.3
—
—
—
0
0
15
167
0.88
0.11
1.7
1.8
0.6
1.4
mg/l
—
10
124
57
550
1.09
0.11
3.2
3.2
—
—
—
0
0
6
54
1.12
0.09
1.3
2.0
—
—
—
0
0
16
173
0.91
0.07
1.4
1.6
—
—
—
0
0
13
138
0.93
0.02
1.5
1.3
1.3
11.7
u/ml
—
6
55
30
292
1.04
0.02
2.0
1.9
94.5
95.0
pmol/l
0.02
15
131
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
5
54
0.92
0.00
1.0
1.4
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
4.8
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_CAROTIDBODY_EXALLC – Benign neoplasm: Carotid body
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).